4.7 Article

HIF1α Represses Cell Stress Pathways to Allow Proliferation of Hypoxic Fetal Cardiomyocytes

期刊

DEVELOPMENTAL CELL
卷 33, 期 5, 页码 507-521

出版社

CELL PRESS
DOI: 10.1016/j.devcel.2015.04.021

关键词

-

资金

  1. Portuguese Foundation for Science and Technology [SFRH/BD/32983/2006]
  2. American Heart Association [10SDG2630130]
  3. NIH [PO1 HL098053-04, DK092062, DK094729, R01HL66100, R01HL106968, HL117649, HL119967, GM068524, P30 NS047101]
  4. Fundação para a Ciência e a Tecnologia [SFRH/BD/32983/2006] Funding Source: FCT

向作者/读者索取更多资源

Transcriptional mediators of cell stress pathways, including HIF1 alpha, ATF4, and p53, are key to normal development and play critical roles in disease, including ischemia and cancer. Despite their importance, mechanisms by which pathways mediated by these transcription factors interact with one another are not fully understood. In addressing the controversial role of HIF1 alpha in cardiomyocytes (CMs) during heart development, we discovered a mid-gestational requirement for HIF1 alpha for proliferation of hypoxic CMs, involving metabolic switching and a complex interplay among HIF1 alpha, ATF4, and p53. Loss of HIF1 alpha resulted in activation of ATF4 and p53, the latter inhibiting CM proliferation. Bioinformatic and biochemical analyses revealed unexpected mechanisms by which HIF1 alpha intersects with ATF4 and p53 pathways. Our results highlight previously undescribed roles of HIF1 alpha and interactions among major cell stress pathways that could be targeted to enhance proliferation of CMs in ischemia and may have relevance to other diseases, including cancer.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Editorial Material Physiology

Deregulated hypoxic response in myeloid cells: A model for high-altitude pulmonary oedema (HAPE) Response

Milos Gojkovic, Pedro Velica, Helene Rundqvist, Randall S. Johnson

ACTA PHYSIOLOGICA (2021)

Article Multidisciplinary Sciences

Divergent Transcription of the Nkx2-5 Locus Generates Two Enhancer RNAs with Opposing Functions

Irene Salamon, Simone Serio, Simona Bianco, Christina Pagiatakis, Silvia Crasto, Andrea M. Chiariello, Mattia Conte, Paola Cattaneo, Luca Fiorillo, Arianna Felicetta, Elisa di Pasquale, Paolo Kunderfranco, Mario Nicodemi, Roberto Papait, Gianluigi Condorelli

ISCIENCE (2020)

Review Biochemistry & Molecular Biology

Oxygen regulation of TET enzymes

Rugile Matuleviciute, Pedro P. Cunha, Randall S. Johnson, Iosifina P. Foskolou

Summary: Hypoxia plays a significant role in physiological and pathological processes, especially in cancer. TET family enzymes are crucial in epigenetic remodelling and cancer development. Inhibiting TETs has shown positive impact in cancer immunotherapy and vaccine studies, highlighting their potential as therapeutic targets.

FEBS JOURNAL (2021)

Article Pharmacology & Pharmacy

In Vivo Functional Effects of CYP2C9 M1L, a Novel and Common Variant in the Yup'ik Alaska Native Population

Lindsay M. Henderson, Scarlett E. Hopkins, Bert B. Boyer, Timothy A. Thornton, Allan E. Rettie, Kenneth E. Thummel

Summary: Alaska Native people have unique gene variations that may impact their response to pharmacotherapy. The novel CYP2C9 Met1Leu variant was identified in this population, with potential clinical implications for drug metabolism. The Leu1 variant enzyme exhibited loss of function, indicating a need for further research on genetic variations in understudied populations.

DRUG METABOLISM AND DISPOSITION (2021)

Article Oncology

Modified Hypoxia-Inducible Factor Expression in CD8+ T Cells Increases Antitumor Efficacy

Pedro Velica, Pedro P. Cunha, Nikola Vojnovic, Iosifina Petrina Foskolou, David Bargiela, Milos Gojkovic, Helene Rundqvist, Randall S. Johnson

Summary: By ectopically expressing the HIF transcription factor in CD8(+) T cells, this study demonstrated an enhanced antitumor efficacy against tumor targets. A specific mutation in HIF2 alpha showed the most effective antitumor T cell response, suggesting a potential strategy to increase therapeutic efficacy of CD8(+) T cells.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Critical Care Medicine

Endothelial cell regulation of systemic haemodynamics and metabolism acts through the HIF transcription factors

Simon Lambden, Andrew S. Cowburn, David Macias, Tessa A. C. Garrud, Bernardo J. Krause, Dino A. Giussani, Charlotte Summers, Randall S. Johnson

Summary: The deficiency of HIF-1 alpha in the systemic or pulmonary endothelium is associated with increased systemic blood pressure and metabolic rate, a pattern that persists in both normoxic conditions and in response to acute stress.

INTENSIVE CARE MEDICINE EXPERIMENTAL (2021)

Article Pharmacology & Pharmacy

Analysis of Drug-Drug Interaction Labeling Language and Clinical Recommendations for Newly Approved Drugs Evaluated With Digoxin, Midazolam, and S-Warfarin

Lindsay M. Henderson, Claire E. Steinbronn, Jingjing Yu, Catherine K. Yeung, Isabelle Ragueneau-Majlessi

Summary: This study focused on evaluating the consistency in drug-drug interaction labeling language in New Drug Applications, finding differences in DDI result presentation and clinical recommendations. Studies with negative results often lacked mechanistic interpretation, limiting the extrapolation of information.

CLINICAL THERAPEUTICS (2021)

Article Medicine, Research & Experimental

Dose-dependent inactivation of airway tryptase with a novel dissociating anti-tryptase antibody (MTPS9579A) in healthy participants: A randomized trial

Sharon M. Rymut, Siddharth Sukumaran, Gizette Sperinde, Meire Bremer, Joshua Galanter, Kenta Yoshida, Jordan Smith, Prajna Banerjee, Viyia Sverkos, Fang Cai, Verena Steffen, Lindsay M. Henderson, Horace Rhee, Paula N. Belloni, Joseph H. Lin, Tracy L. Staton

Summary: Tryptase is an important protein in asthma pathogenesis, and MTPS9579A is a novel monoclonal antibody that selectively inhibits its activity. The study showed that MTPS9579A has good safety and tolerability in healthy participants, with significant inhibition of active tryptase.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2022)

Article Immunology

Vitamin B6 Metabolism Determines T Cell Anti-Tumor Responses

David Bargiela, Pedro P. Cunha, Pedro Velica, Iosifina P. Foskolou, Laura Barbieri, Helene Rundqvist, Randall S. Johnson

Summary: Targeting T cell metabolism, specifically vitamin B6 metabolism, can improve anti-tumor immunotherapy by affecting CD8+ T cell proliferation and effector differentiation.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

Fate mapping and scRNA sequencing reveal origin and diversity of lymph node stromal precursors

Elisa Lenti, Luca Genovese, Silvia Bianchessi, Aurora Maurizio, Simona Baghai Sain, Alessia di Lillo, Greta Mattavelli, Itamar Harel, Francesca Bernassola, Thomas Hehlgans, Klaus Pfeffer, Mariacristina Crosti, Sergio Abrignani, Sylvia M. Evans, Giovanni Sitia, Nuno Guimaraes-Camboa, Vincenzo Russo, Serge A. van de Pavert, Jose Manuel Garcia-Manteiga, Andrea Brendolan

Summary: This study identifies the origin and composition of lymph node stromal and endothelial cells through lineage tracing and single-cell transcriptome analysis. The results show that stromal and endothelial cells originate from different cell populations in the embryo. Single-cell RNA sequencing reveals different subsets of stromal cells and suggests the presence of proliferating progenitors in embryonic lymph nodes.

IMMUNITY (2022)

Article Engineering, Biomedical

Myocardial matrix hydrogel acts as a reactive oxygen species scavenger and supports a proliferative microenvironment for cardiomyocytes

Raymond M. Wang, Joshua M. Mesfin, Jervaughn Hunter, Paola Cattaneo, Nuno Guimaraes-Camboa, Rebecca L. Braden, Colin Luo, Ryan C. Hill, Monika Dzieciatkowska, Kirk C. Hansen, Sylvia Evans, Karen L. Christman

Summary: This study demonstrates that myocardial matrix hydrogel exhibits the ability to scavenge reactive oxygen species and protect cells from oxidative stress, as well as enhance cell proliferation. In in vivo experiments using a rat myocardial infarction model, animals treated with matrix injection showed increased thymidine analog uptake in cardiomyocytes, reduced oxidative damage, and improved preservation of tissue free thiol content compared to saline controls. Overall, this study provides evidence that the properties of the myocardial matrix material create a supportive microenvironment for cardiomyocytes undergoing DNA synthesis, potentially facilitating DNA repair or cell cycle activation.

ACTA BIOMATERIALIA (2022)

Letter Cardiac & Cardiovascular Systems

Increasing Mononuclear Diploid Cardiomyocytes by Loss of E2F Transcription Factor 7/8 Fails to Improve Cardiac Regeneration After Infarct

Zhe Yu, Lunfeng Zhang, Paola Cattaneo, Nuno Guimaraes-Camboa, Xi Fang, Yusu Gu, Kirk L. Peterson, Julius Bogomolovas, Cecilia Cuitino, Gustavo W. Leone, Ju Chen, Sylvia M. Evans

CIRCULATION (2023)

Article Multidisciplinary Sciences

DOT1L regulates chamber-specific transcriptional networks during cardiogenesis and mediates postnatal cell cycle withdrawal

Paola Cattaneo, Michael G. B. Hayes, Nina Baumgarten, Dennis Hecker, Sofia Peruzzo, Galip S. Aslan, Paolo Kunderfranco, Veronica Larcher, Lunfeng Zhang, Riccardo Contu, Gregory Fonseca, Simone Spinozzi, Ju Chen, Gianluigi Condorelli, Stefanie Dimmeler, Marcel H. Schulz, Sven Heinz, Nuno Guimaraes-Camboa, Sylvia M. Evans

Summary: This study reveals that H3K79me2, a modification catalyzed by DOT1L, plays a specific role in regulating gene expression during cardiogenesis. It is important for left ventricle-specific genes during embryonic cardiogenesis and is involved in postnatal cardiomyocyte cell cycle withdrawal. Mechanistic analyses show that H3K79me2 in gene bodies and regulatory elements synergistically promote gene expression activated by DOT1L. Additionally, H3K79me2 in specific regulatory elements also contributes to silencing genes not usually expressed in cardiomyocytes.

NATURE COMMUNICATIONS (2022)

Article Medicine, Research & Experimental

A mechanistic PK/PD model to enable dose selection of the potent anti-tryptase antibody (MTPS9579A) in patients with moderate-to-severe asthma

Sharon M. Rymut, Lindsay M. Henderson, Victor Poon, Tracy L. Staton, Fang Cai, Siddharth Sukumaran, Horace Rhee, Ryan Owen, Saroja Ramanujan, Kenta Yoshida

Summary: The study assessed the relationship between MTPS9579A concentrations and tryptase levels in healthy subjects and patients with moderate-to-severe asthma. A PK/PD model was developed to quantitatively relate MTPS9579A exposure and inhibition of active tryptase in the airway. The model predicted almost complete neutralization of active tryptase with MTPS9579A doses of 900 mg and greater in patients with asthma.

CTS-CLINICAL AND TRANSLATIONAL SCIENCE (2023)

Article Cell Biology

The two enantiomers of 2-hydroxyglutarate differentially regulate cytotoxic T cell function

Iosifina P. Foskolou, Pedro P. Cunha, Elena Sanchez-Lopez, Eleanor A. Minogue, Beno P. Nicolet, Aurelie Guislain, Christian Jorgensen, Sarantos Kostidis, Nordin D. Zandhuis, Laura Barbieri, David Bargiela, Demitris Nathanael, Petros A. Tyrakis, Asis Palazon, Martin Giera, Monika C. Wolkers, Randall S. Johnson

Summary: 2-Hydroxyglutarate (2HG) is a byproduct of the tricarboxylic acid (TCA) cycle, found in two enantiomeric forms. The study investigates the differential roles of these two enantiomers in CD8+ T cell biology and reveals their divergent effects on proliferation, differentiation, and T cell function. Treatment with exogenous S-2HG enhances CD8+ T cell fitness and anti-tumor activity, highlighting the importance of considering S-2HG and R-2HG as distinct regulatory factors in T cell function.

CELL REPORTS (2023)

暂无数据